Hadrian announces $40M Series B led by Forgepoint and SmartFin
The October 6 announcement sets out expansion and product investment plans; the supplied material describes no regulatory action or legal proceeding.
Hadrian announced a $40 million Series B on October 6, 2026, taking its total funding to $65M. The Amsterdam cybersecurity company said the round will finance expansion across EMEA and the U.S. and further investment in engineering and research. Forgepoint Capital International and SmartFin co-led the financing, with existing investors participating. The supplied material records a funding announcement, rather than a regulatory decision or legal proceeding.
Hadrian said the funds will support a wider regional presence and work on its platform. The announcement does not set out specific markets, milestones, hiring plans or an implementation timetable. It also gives no allocation between expansion, engineering and research. No regulatory authority, legal status or company response to a regulatory matter is identified in the supplied material.
The announcement sets out funding terms
The funding described is a Series B round totalling $40 million. Forgepoint Capital International and SmartFin are named as co-leads, and HV Capital, Motive Partners, Picus Capital and Oetker Ventures are listed as participating existing investors. Hadrian says the investment brings its cumulative funding to $65M. The source does not state a company valuation, investor-by-investor contributions or other financing terms.
The announcement is dated October 6, 2026, and identifies Hadrian as based in Amsterdam. Its stated use of proceeds is expansion across EMEA and the U.S., together with greater investment in engineering and research. The supplied information does not describe a regulatory filing, authorisation request, investigation or other formal legal step. It gives no indication that a public authority reviewed or approved the financing.
Hadrian describes its security platform
Hadrian characterises its business as an agentic AI offensive security platform. Its announcement says the platform maps an organisation’s digital footprint, identifies risks and helps security teams prioritise remediation. In plain terms, the described service is intended to help teams establish which exposures could be exploited and what needs attention. These are the company’s descriptions of its product and purpose.
The supplied facts identify Atlas as a product. Hadrian’s announcement says Atlas continuously maps an organisation’s external attack surface and applies AI agents to validate which exposures are exploitable. The announcement also reports customer outcomes of 10x greater visibility into critical risks, 80% faster time to resolution and 5x ROI compared with manual pentesting. These are reported company claims; the source material provides no measurement method or independent verification.
Hadrian’s source also presents figures about the wider security workload. It says 87% of organisations still run manual penetration tests, more than 70% of security teams struggle to determine which exposures are exploitable, and 0.47% of vulnerability scanner findings proved genuinely exploitable. The figures are attributed to Hadrian’s announcement. No underlying study, regulator or independent data source is included in the supplied materials, so they cannot be treated here as findings of an authority.
No legal proceeding is identified
The available sources contain no named regulator, legal allegation, formal investigation, provisional finding, decision or appeal concerning Hadrian. They also do not set out a legal status or a company response to any authority. Accordingly, the funding announcement does not establish a regulatory stage or any legal finding. The company’s stated position is limited to the planned use of proceeds and its description of the platform.
The next material disclosures would be details on the planned regional expansion and investment in engineering and research. The sources do not state when those plans will be implemented or how progress will be reported. They also do not provide additional financing terms or independent validation of the product performance figures.